Shanghai Kehua Bio-Engineering Co., Ltd. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Kehua Bio-Engineering Co., Ltd. with three other
companies in this sector in China:
DA AN Gene Co.,Ltd. Of Sun Yat-Sen University
sales of 1.54 billion Chinese Renmimbi [US$245.83 million]
of which 95%
was Biological Products),
Getein Biotech Inc
(488.58 million Chinese Renmimbi [US$77.88 million]
Beijing Strong Biotechnologies Inc
(694.28 million Chinese Renmimbi [US$110.66 million]
of which 92%
was In Vitro Test Reagents).
During the year ended December of 2017, sales at
Shanghai Kehua Bio-Engineering Co., Ltd. were 1.59 billion Chinese Renmimbi (US$254.09 million).
increase of 14.1%
versus 2016, when the company's sales were 1.40 billion Chinese Renmimbi.